{"favorite_id": 3818, "full_title_en": "Dutch Criteria for Familial Hypercholesterolemia (FH)", "short_title_en": "Dutch Criteria for FH", "medium_description_en": "Diagnoses familial hypercholesterolemia (FH) based on clinical, genetic and family history.", "short_description_en": "Diagnoses familial hypercholesterolemia.", "calc_type": "diagnostic_criteria", "specialty_en": ["Endocrinology", "Family Practice", "Internal Medicine", "Pediatrics"], "system_en": ["Endocrine and Metabolic"], "disease_en": ["Dyslipidemia"], "chief_complaint_en": ["Chest Pain", "Mass"], "purpose_en": ["Diagnosis"], "search_abbreviation_en": ["FH", "HoFH", "HeFH", "high cholesterol", "dna", "hypercholesterolemia", "familial"], "seo": {"meta_description_en": "The Dutch Criteria for Familial Hypercholesterolemia diagnoses familial hypercholesterolemia (FH) based on clinical, genetic and family history.", "keywords_en": "FH, HoFH, HeFH, high cholesterol, dna, dutch criteria, dutch cholesterol criteria, dna, Xanthomas, Arcus cornealis"}, "content": {"how_to_use": {"use_case_en": "<p>Patients with suspected familial hypercholesterolemia (FH), including those with elevated cholesterol and/or family history of premature cardiac events.</p>", "pearls_pitfalls_en": "<ul> <li>Assigns points to risk factors and stratifies likelihood of diagnosis into one of four categories: definite, probable, possible, and unlikely.</li> <li>Requires DNA testing for completeness.</li> </ul>", "why_use_en": "<ul> <li>FH is underdiagnosed and carries significant mortality risk from cardiac events.</li> <li>The European Atherosclerosis Society recommends that the Dutch Criteria be used to diagnose FH.</li> <li>Alternative diagnostic criteria include <calculator id=\"3820\">US MEDPED</calculator> and the <calculator id=\"3817\">Simon Broome Diagnostic Criteria</calculator>. The risk factors in each criteria set are similar, and clinical judgment as well as local practice factors (similarity of target population to study population) should be considered.</li> </ul>"}, "next_steps": {"advice_en": "<p>Consider lifestyle changes, drug therapy, family testing, and other measures to manage FH if diagnosed.</p>", "management_en": "", "critical_actions_en": ""}, "about": {"formula_en": "<p>&nbsp;</p> <div class=\"table-responsive\"> <table class=\"table table-bordered\"> <tbody> <tr> <td> <p><strong>Criteria</strong></p> </td> <td> <p><strong>Points</strong></p> </td> </tr> <tr> <td> <p><strong>Family history</strong></p> </td> <td>&nbsp;</td> </tr> <tr> <td> <p>First-degree relative with known premature* coronary and vascular disease, OR</p> <p>First-degree relative with known LDL-C level above the 95th percentile</p> </td> <td> <p>1</p> </td> </tr> <tr> <td> <p>First-degree relative with tendinous xanthomata and/or arcus cornealis, OR</p> <p>Children &lt;18 years with LDL-C level above the 95th percentile</p> </td> <td> <p>2</p> </td> </tr> <tr> <td> <p><strong>Clinical history</strong></p> </td> <td>&nbsp;</td> </tr> <tr> <td> <p>Patient with premature* coronary artery disease</p> </td> <td> <p>2</p> </td> </tr> <tr> <td> <p>Patient with premature* cerebral or peripheral vascular disease</p> </td> <td> <p>1</p> </td> </tr> <tr> <td> <p><strong>Physical examination</strong></p> </td> <td>&nbsp;</td> </tr> <tr> <td> <p>Tendinous xanthomata</p> </td> <td> <p>6</p> </td> </tr> <tr> <td> <p>Arcus cornealis prior to age 45 years</p> </td> <td> <p>4</p> </td> </tr> <tr> <td> <p><strong>Cholesterol level, mmol/L (mg/dL)</strong></p> </td> <td>&nbsp;</td> </tr> <tr> <td> <p>LDL-C \u22658.5 (330)</p> <p>LDL-C 6.5 - 8.4 (250 - 329)</p> <p>LDL-C 5.0 - 6.4 (190 - 249)</p> <p>LDL-C 4.0 - 4.9 (155 - 189)</p> </td> <td> <p>8</p> <p>5</p> <p>3</p> <p>1</p> </td> </tr> <tr> <td> <p>DNA analysis \u2013 functional mutation LDLR, apoB and PCSK9</p> </td> <td> <p>1</p> </td> </tr> </tbody> </table> </div> <p><br>* Premature = &lt;55 years in men; &lt;60 years in women.</p> <p>From the <a href=\"http://nlaresourcecenter.lipidjournal.com/Content/PDFs/Tables/4.pdf\" target=\"_blank\">National Lipid Association Resource Center</a>.</p>", "more_info_en": "<p><strong>Score interpretation:</strong></p> <div class=\"table-responsive\"> <table class=\"table table-bordered table-hover\"> <tbody> <tr> <th><strong>Stratification</strong></th> <th><strong>Total Score</strong></th> </tr> <tr> <td>Definite familial hypercholesterolemia</td> <td>&gt;8</td> </tr> <tr> <td>Probable familial hypercholesterolemia</td> <td>6-8</td> </tr> <tr> <td>Possible familial hypercholesterolemia</td> <td>3-5</td> </tr> <tr> <td>Unlikely familial hypercholesterolemia</td> <td>&lt;3</td> </tr> </tbody> </table> </div>", "evidence_based_medicine_en": "<p>The Dutch Criteria were constructed by the Dutch Lipid Clinic Network to identify patients with familial hypercholesterolemia based on known risk factors.</p>", "references_list": {"Original/Primary Reference": [{"href": "http://apps.who.int/iris/bitstream/10665/66346/1/WHO_HGN_FH_CONS_99.2.pdf ", "text": "World Health Organization. Familial hypercholesterolemia\u2014report of a second WHO Consultation. Geneva, Switzerland: World Health Organization, 1999. (WHO publication no. WHO/HGN/FH/CONS/99.2)."}], "Other References": [{"href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976735/", "text": "Al-Rasadi K, Al-Waili K, Al-Sabti HA, et al. Criteria for Diagnosis of Familial Hypercholesterolemia: A Comprehensive Analysis of the Different Guidelines, Appraising their Suitability in the Omani Arab Population. Oman Medical Journal. 2014;29(2):85-91. doi:10.5001/omj.2014.22."}, {"href": "https://www.ncbi.nlm.nih.gov/pubmed/15321837", "text": "Austin MA, Hutter CM, Zimmern RL, Humphries SE. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review. Am J Epidemiol 2004. Sep;160(5):407-420 10.1093/aje/kwh236"}, {"href": "http://nlaresourcecenter.lipidjournal.com/Content/PDFs/Tables/4.pdf", "text": "National Lipid Association Clinical Lipidology Resource Center"}], "Clinical Practice Guidelines": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/23956253", "text": "Nordestgaard BG, Chapman MJ, Humphries SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013;34(45):3478-90a."}]}}, "contributor": {"expert_name": []}, "creator": [{"name": "Dr. Melissa Austin", "qa_en": "", "creator_info": {"about_en": "<p>Melissa Austin, PhD, MS, is a professor emeritus of epidemiology at the University of Washington. Her research spans many areas including genetic epidemiology of chronic diseases, lipoprotein metabolism and pancreatic cancer.</p>", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-melissa-austin.jpeg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Austin+MA%5BAuthor%5D"}}]}, "instructions_en": "", "input_schema": [{"type": "subheading", "subheading": "Entry Criterion", "subheading_instructions": "If yes, 9+ additional criteria required for Definite FH"}, {"label_en": "Patient has elevated cholesterol, family history of FH, and/or family history of premature cardiac death", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "show_points": false, "type": "radio", "name": "entry", "optional": false}, {"type": "subheading", "subheading": "Family History", "subheading_instructions": ""}, {"label_en": "First-degree relative with premature coronary and/or vascular disease", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "default": 0, "show_points": false, "tips_en": "Male relative <55 years, female relative <60 years", "conditionality": "entry == 1", "type": "toggle", "name": "relative_corvasc", "optional": false}, {"label_en": "First-degree relative with known LDL >95th percentile for age and sex", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "default": 0, "show_points": false, "conditionality": "entry == 1", "type": "toggle", "name": "relative_ldl95", "optional": false}, {"label_en": "First-degree relative with tendon xanthomata and/or arcus cornealis", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 2}], "default": 0, "show_points": false, "conditionality": "entry == 1", "type": "toggle", "name": "relative_xan", "optional": false}, {"label_en": "Children <18 years with known LDL >95th percentile for age and sex", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 2}], "default": 0, "show_points": false, "conditionality": "entry == 1", "type": "toggle", "name": "child_ldl95", "optional": false}, {"type": "subheading", "subheading": "Clinical History", "subheading_instructions": ""}, {"label_en": "Patient with premature coronary artery disease", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 2}], "default": 0, "show_points": true, "conditionality": "entry == 1", "type": "toggle", "name": "premcad", "optional": false}, {"label_en": "Patient with premature cerebral or peripheral vascular disease", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 1}], "default": 0, "show_points": true, "conditionality": "entry == 1", "type": "toggle", "name": "premvasc", "optional": false}, {"type": "subheading", "subheading": "Physical Examination", "subheading_instructions": ""}, {"label_en": "Tendon xanthomata", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 6}], "default": 0, "show_points": true, "conditionality": "entry == 1", "type": "toggle", "name": "xan", "optional": false}, {"label_en": "Arcus cornealis at age <45 years", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 4}], "default": 0, "show_points": true, "conditionality": "entry == 1", "type": "toggle", "name": "arcus", "optional": false}, {"type": "subheading", "subheading": "Cholesterol Level", "subheading_instructions": ""}, {"label_en": "LDL in mmol/L (mg/dL)", "options": [{"label": "LDL-C \u22658.5 (330)", "value": 8}, {"label": "LDL-C 6.5 - 8.4 (250 - 329)", "value": 5}, {"label": "LDL-C 5.0 - 6.4 (190 - 249)", "value": 3}, {"label": "LDL-C 4.0 - 4.9 (155 - 189)", "value": 1}], "show_points": true, "conditionality": "entry == 1", "type": "radio", "name": "ldl", "optional": false}, {"type": "subheading", "subheading": "DNA Analysis", "subheading_instructions": ""}, {"label_en": "Functional mutation of LDLR, apoB or PCSK9 gene", "options": [{"label": "No", "value": 0}, {"label": "Yes", "value": 8}], "default": 0, "show_points": true, "conditionality": "entry == 1", "type": "toggle", "name": "dna", "optional": false}], "slug": "dutch-criteria-familial-hypercholesterolemia-fh", "dosing": false, "before_use": "", "md5": "595cee8bf9bc7a1dc572e61d9f552a9e", "related_calcs": [{"calcId": 3820, "short_title_en": "US (MEDPED) Diagnostic Criteria for FH", "slug": "us-medped-diagnostic-criteria-familial-hypercholesterolemia-fh"}, {"calcId": 3817, "short_title_en": "Simon Broome Diagnostic Criteria", "slug": "simon-broome-diagnostic-criteria-familial-hypercholesterolemia-fh"}, {"calcId": 70, "short_title_en": "LDL Calculated", "slug": "ldl-calculated"}]}